Superior Hypogastric Plexus Block to Reduce Pain After Laparoscopic Hysterectomy: A Randomized Controlled Trial.
Nisse V Clark, Kristin Moore, Parmida Maghsoudlou...
https://pubmed.ncbi.nlm.nih.gov/33706344/Actively Recruiting
Led by Cedars-Sinai Medical Center · Updated on 2026-09-30
100
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether applying sprayed bupivacaine with epinephrine over the diaphragm can reduce postoperative shoulder pain in patients undergoing benign laparoscopic gynecologic surgery. This randomized, controlled trial compares this treatment against a placebo saline to assess its effect on pain management after surgery. The study is conducted at Cedars-Sinai Medical Center and focuses on women aged 18 years or older. Participants are randomly assigned to receive either 30 mL of 0.25% bupivacaine with epinephrine applied laparoscopically over the diaphragm at the end of their surgery or no additional intervention placebo. This phase 4 trial aims to prevent postoperative shoulder pain by assessing the effect of this local anesthetic during laparoscopic procedures. During the study, participants will be monitored for shoulder pain scores 24 hours after surgery as the primary outcome. Secondary measures include pain scores up to 6 hours post-anesthesia care, total analgesic use, length of stay in the post-anesthesia care unit, opioid use up to one week post-surgery, and surgical outcomes such as blood loss, operative time, complications, and conversion to open surgery. Participants will be followed closely during the immediate postoperative period and up to one week after surgery.
CONDITIONS
Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy
O
Ogechukwu Ezike, MD
K
Kelly Wright, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cedars-Sinai Medical Center
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Bupivacaine with Epinephrine Instillation | No Additional Intervention |
|---|---|---|
| What it is | A local anesthetic solution (bupivacaine with epinephrine) is instilled over the diaphragm through a laparoscopic port before the completion of minimally invasive gynecologic surgery. The aim is to cover the diaphragm surface to reduce post-operative pain. | Participants do not receive any additional anesthetic or other instillation over the diaphragm during laparoscopic gynecologic surgery. They receive the usual perioperative care. |
| Role in the trial | The investigational arm. Tests whether diaphragm instillation of bupivacaine with epinephrine reduces post-operative shoulder and generalized pain compared with the control group. | The control arm. Participants receive no additional intervention over the diaphragm and serve as the comparison group for assessing pain and recovery outcomes. |
| Primary use | To prevent and reduce post-operative shoulder pain and overall pain after minimally invasive gynecologic surgery, potentially reducing the need for opioid analgesics. | Standard perioperative care without an attempt to prevent shoulder pain via local anesthetic instillation. Shoulder and general pain are managed as per routine practice and recorded for study analysis. |
| How it is given or performed | The surgeon instills 30mL of 0.25% bupivacaine with epinephrine 1:200,000 laparoscopically over the diaphragm before abdominal desufflation, aiming for broad diaphragm coverage. | No liquid or intervention is applied over the diaphragm. Standard surgical procedures are performed without an additional local anesthetic step. |
| Evidence status | The effectiveness of instilling bupivacaine with epinephrine over the diaphragm to reduce post-operative pain after laparoscopic gynecologic surgery is under investigation. Previous studies and systematic reviews suggest that intraperitoneal local anesthetics may lower post-operative pain scores and opioid requirements, but results are variable depending on administration approach. | Standard care without local anesthetic instillation typically results in higher rates of post-operative shoulder pain, which is a recognized common issue after laparoscopic surgery. |
| Important limitations | The effectiveness of bupivacaine with epinephrine instillation over the diaphragm may depend on specific surgical technique, instillation volume, patient anatomy, and timing during the procedure. There is variability in outcome across studies. Additional safety data are needed as there are limited large-scale randomized studies focused on this method. | Standard care without instillation does not address post-operative shoulder pain, and many patients experience significant discomfort after laparoscopic gynecologic surgery. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Surgery day
Participants receive either bupivacaine with epinephrine applied laparoscopically over the diaphragm at the end of surgery or no additional intervention as a placebo.
1 visit (surgery day)
Duration - 7 days post-surgery
Participants are monitored for shoulder pain, analgesic use, and surgical outcomes up to 7 days after surgery.
Follow-up assessments up to 7 days
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nisse V Clark, Kristin Moore, Parmida Maghsoudlou...
https://pubmed.ncbi.nlm.nih.gov/33706344/Pavit Sutchritpongsa, Pakprapa Chaipakdi, Korakot Sirimai...
https://pubmed.ncbi.nlm.nih.gov/23745303/Thomas Jaschinski, Christoph Mosch, Michaela Eikermann...
https://pubmed.ncbi.nlm.nih.gov/25884671/Liyan Miao, Qiuchun Chen, Yuping Wang...
https://pubmed.ncbi.nlm.nih.gov/37004537/Nalini Vadivelu, Sukanya Mitra, Deepak Narayan
https://pubmed.ncbi.nlm.nih.gov/20351978/N Johnson, D Barlow, A Lethaby...
https://pubmed.ncbi.nlm.nih.gov/16625589/American Society of Anesthesiologists Task Force on Acute Pain Management
https://pubmed.ncbi.nlm.nih.gov/22227789/Olga Bougie, Jessica Blom, Grace Zhou...
https://pubmed.ncbi.nlm.nih.gov/35973919/Emily Blanton, Georgine Lamvu, Insiyyah Patanwala...
https://pubmed.ncbi.nlm.nih.gov/28043841/Marianna Alperin, Seth Kivnick, Kwun Yee Trudy Poon
https://pubmed.ncbi.nlm.nih.gov/23084671/Cedars-Sinai Medical Center
Lead Sponsor